Candesartan-Amlodipin-Mepha 8 mg/5 mg
Candesartan-Amlodipin-Mepha 8 mg/5 mg is a medicine authorised by Swissmedic under authorisation number 67656. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 23 December 2020 and the authorisation is valid without a time limit. ATC code C09DB07 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 67656 |
|---|---|
| Name | Candesartan-Amlodipin-Mepha 8 mg/5 mg |
| Full name | Candesartan-Amlodipin-Mepha 8 mg/5 mg, Hartkapseln |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09DB07 |
| First authorisation | 23 December 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Candesartan-Amlodipin-Mepha 8 mg/5 mg, Hartkapseln | B | 23 December 2020 |
| 2 | Candesartan-Amlodipin-Mepha 16 mg/5 mg, Hartkapseln | B | 23 December 2020 |
| 3 | Candesartan-Amlodipin-Mepha 8 mg/10 mg, Hartkapseln | B | 23 December 2020 |
| 4 | Candesartan-Amlodipin-Mepha 16 mg/10 mg, Hartkapseln | B | 23 December 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Kapsel(n) | C09DB07 | 02.07.1. | B |
| 2 | 98 | Kapsel(n) | C09DB07 | 02.07.1. | B |
| 3 | 28 | Kapsel(n) | C09DB07 | 02.07.1. | B |
| 4 | 98 | Kapsel(n) | C09DB07 | 02.07.1. | B |
| 5 | 28 | Kapsel(n) | C09DB07 | 02.07.1. | B |
| 6 | 98 | Kapsel(n) | C09DB07 | 02.07.1. | B |
| 7 | 28 | Kapsel(n) | C09DB07 | 02.07.1. | B |
| 8 | 98 | Kapsel(n) | C09DB07 | 02.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Candesartan-Amlodipin-Mepha 8 mg/5 mg authorised in Switzerland?
Yes. Candesartan-Amlodipin-Mepha 8 mg/5 mg is authorised by Swissmedic under authorisation number 67656, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Candesartan-Amlodipin-Mepha 8 mg/5 mg have?
Candesartan-Amlodipin-Mepha 8 mg/5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Candesartan-Amlodipin-Mepha 8 mg/5 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.